CTI settles with GE

Article

Litigation involving CTI Molecular Imaging and GE has been settled out of court. The lawsuits were initially brought by GE against CTI Molecular Imaging, its PETNET Solutions radiopharmaceuticals unit, and certain employees of CTI Molecular Imaging to

Litigation involving CTI Molecular Imaging and GE has been settled out of court. The lawsuits were initially brought by GE against CTI Molecular Imaging, its PETNET Solutions radiopharmaceuticals unit, and certain employees of CTI Molecular Imaging to prevent these former GE employees from potentially disclosing or using GE confidential information. The staff had left GE and joined CTI or PETNET before the litigation was initiated. CTI Molecular Imaging announced that the parties worked together to ensure that sufficient safeguards were in place to prevent potential disclosure of GE confidential information and further disputes. CTI Molecular Imaging will incur no charges in connection with the settlement.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.